PAREXEL International Corp. (PRXL) Updates FY14 Earnings Guidance
PAREXEL International Corp. (NASDAQ:PRXL) issued an update on its FY14 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $1.95 – $2.11 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.06, American Banking News reports. The company issued revenue guidance of $1.890 – $1.920 billion, compared to the consensus revenue estimate of $1.92 billion.
A number of research firms have recently commented on PRXL. Analysts at Robert W. Baird downgraded shares of PAREXEL International Corp. from an outperform rating to a neutral rating in a research note to investors on Friday. They noted that the move was a valuation call. On a related note, analysts at Sterne Agee reiterated an underperform rating on shares of PAREXEL International Corp. in a research note to investors on Monday, October 7th. They now have a $51.07 price target on the stock, up previously from $36.00. Finally, analysts at ISI Group upgraded shares of PAREXEL International Corp. from a neutral rating to a buy rating in a research note to investors on Friday, October 4th. They now have a $57.00 price target on the stock, up previously from $52.50. One research analyst has rated the stock with a sell rating, six have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of Hold and an average price target of $49.88.
PAREXEL International Corp. (NASDAQ:PRXL) traded up 0.73% during mid-day trading on Tuesday, hitting $54.85. 503,555 shares of the company’s stock traded hands. PAREXEL International Corp. has a one year low of $27.50 and a one year high of $53.55. The stock’s 50-day moving average is $48.71 and its 200-day moving average is $44.69. The company has a market cap of $3.084 billion and a P/E ratio of 33.82.
PAREXEL International Corp. (NASDAQ:PRXL) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.45 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.45. The company had revenue of $449.20 million for the quarter, compared to the consensus estimate of $458.94 million. During the same quarter in the prior year, the company posted $0.29 earnings per share. The company’s quarterly revenue was up 13.8% on a year-over-year basis. On average, analysts predict that PAREXEL International Corp. will post $2.04 earnings per share for the current fiscal year.
PAREXEL International Corporation (NASDAQ:PRXL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.